Get started
Author

Zakaria Einbeigi

Observed name: Einbeigi, Zakaria
ORCID: 0000-0003-2507-7197
Observed ORCID: 0000-0003-2507-7197
OpenAlex ID: A5062857865
Pan-cancer analysis identifies BIRC5 as a prognostic biomarker
2022 · Anna Fäldt Beding, Peter Larsson, et al. · BMC Cancer · 82
PDF
Tailored Dose-Dense Versus Standard Adjuvant Chemotherapy for High-Risk Early Breast Cancer: End-of-Study Results of the Randomized PANTHER Trial
2024 · Alexios Matikas, Volker Möbus, et al. · Journal of Clinical Oncology · 16
PDF
Functional assessment in vitro of human-complement-dependent antibody-induced cytotoxicity of neoplastic cells
2000 · Thomas Brezicka, Zakaria Einbeigi, et al. · Cancer Immunology Immunotherapy · 10
The role of serum thymidine kinase 1 activity in neoadjuvant-treated HER2-positive breast cancer: biomarker analysis from the Swedish phase II randomized PREDIX HER2 trial
2024 · Yajing Zhu, Ioannis Zerdes, et al. · Breast Cancer Research and Treatment · 7
PDF
Randomised trial of trastuzumab deruxtecan and biology-driven selection of neoadjuvant treatment for HER2-positive breast cancer: a study protocol of ARIADNE
2025 · Alexios Matikas, Bjørn Naume, et al. · BMJ Open · 2
Omission of postoperative radiotherapy after breast-conserving surgery in low-risk breast cancer
2024 · Sofia Palmér, Antonis Valachis, et al. · JNCI Journal of the National Cancer Institute · 2
PDF
Serum thymidine kinase 1 and its kinetics in HER2-positive breast cancer: Results from the Swedish phase II PREDIX HER2 trial.
2022 · Yajing Zhu, Kang Wang, et al. · Journal of Clinical Oncology · 1
Population-scale integration of tumor transcriptomics into breast cancer care: a decade of the SCAN-B initiative
2026 · Lao H. Saal, Hina Dalal, et al. · medRxiv
PDF
Abstract P5-02-20: Correlative and longitudinal transcriptomic profiling predicts patient outcomes and the efficacy of neoadjuvant HER2-targeted treatments in the randomized PREDIX HER2 trial
2023 · Kang Wang, Yajing Zhu, et al. · Cancer Research
Additional file 2 of Pan-cancer analysis identifies BIRC5 as a prognostic biomarker
2022 · Fäldt Beding, Anna, Larsson, Peter, et al. · Figshare
Works count: 11
Citation count: 119
H-index: 4
I10-index: 3
Year
Topic
Type